Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Apr 20, 2020 (6 years ago)

ChapStick Total Hydration Moisture + Tint + SPF15 Very Berry Net Wt. 0.08 OZ (Zinc Oxide)

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer card

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

ChapStick Total Hydration Moisture + Tint + SPF15 Very Berry Net Wt. 0.08 OZ (2.2g) Marketed by: Pfizer, Madison, NJ 07940 USA NDC 0573-0872-08

Affected NDC 0573-0872-08

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Chapstick Total Hydration Moisture Tint Very Berry
zinc oxide
NDC 00573-0872
101 mg/g Stick
Topical
Haleon US Holdings LLC OTC
Recalling firm
Glaxosmithkline Consumer Healthcare Holdings
NDC code
0573-0872-08
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1267-2020 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Glaxosmithkline Consumer Healthcare Holdings

All 2020 recalls
Class I · High risk

Advil Liqui Gels

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Terminated Labeling / mix-up Glaxosmithkline Consumer Healthcare Holdings DBA Haleon D-0183-2023
Class I · High risk

Advil Liqui Gels

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Terminated Labeling / mix-up Glaxosmithkline Consumer Healthcare Holdings DBA Haleon D-0182-2023
Class I · High risk

Advil (ibuprofen)

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Terminated Labeling / mix-up Glaxosmithkline Consumer Healthcare Holdings DBA Haleon D-0181-2023
Class II · Moderate risk

TUMS Antacid

Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

Completed Particulate / foreign matter GlaxoSmithKline Consumer Healthcare Holdings LLC D-0079-2024

Other labeling / mix-up recalls from 2020

All labeling / mix-up recalls